Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,469,947 papers from all fields of science
Search
Sign In
Create Free Account
naratriptan
Known as:
naratriptan [Chemical/Ingredient]
, N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide
, N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Narrower (3)
Amerge
Colatan
Naramig
Angina Pectoris, Variant
Cerebral Arterial Vasoconstriction [PE]
Cerebrovascular accident
Drug Allergy
Expand
Broader (4)
Piperidines
Serotonin 5-HT1 Receptor Agonists
Tryptamines
Vasoconstrictor Agents
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF NARATRIPTAN USING SUBLIMATION TECHNIQUE
N. Kshirasagar
,
S. Malvey
,
K. S. Kumar
,
C. Vijaya
,
M. V. Reddy
2016
Corpus ID: 212554374
Orodispersible Tablets (ODT) of Naratriptan a typical anti migraine is highly appropriate, as it has ease of administration for…
Expand
2013
2013
Novel Spectrophotometric Methods for Estimation of Naratriptan in Pharmaceutical Dosage Forms
A. Sreelakshmi
,
G. D. Rao
,
G. Babu
2013
Corpus ID: 59383134
Naratriptan is a triptan drug. Two simple, sensitive and accurate spectrophotometric methods have been developed for the…
Expand
2011
2011
Method development and validation for naratriptan determination in human plasma by HPLC with tandem mass spectrometry detection , and its application to bioequivalence study
B. R. Challa
,
B. Z. Awen
,
B. Chandu
,
R. P. Shaik
2011
Corpus ID: 39478065
The authors developed a simple, sensitive and specific liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for the…
Expand
Review
2006
Review
2006
Utilisation clinique des triptans dans la prise en charge de la migraine
M. Lanteri-minet
2006
Corpus ID: 73004320
The discovery of the triptans (selective serotonin agonists 5HT1B/1D), with 7 compounds (almotriptan, eletriptan, frovatriptan…
Expand
2005
2005
Naratriptan in the Preventive Treatment of Refractory Transformed Migraine: A Prospective Pilot Study
F. Sheftell
,
A. Rapoport
,
S. Tepper
,
M. Bigal
Headache
2005
Corpus ID: 6341621
Objective.—To assess the efficacy, safety, and tolerability of daily naratriptan in the preventive treatment of transformed…
Expand
2005
2005
Triptans for Migraine Therapy: A Comparison Based on Number Needed to Treat and Doses Needed to Treat
PhD C. DANIEL MULLINS
,
DrPH KATHLEEN A. WEIS
,
SR PAUL J. HEALEY
,
P. M. Eleanor M. Perfetto
,
PhD Daniel Mullins
,
MS PRASUN R. SUBEDI
Journal of Managed Care Pharmacy
2005
Corpus ID: 261072955
OBJECTIVES: Managed care and other decision makers need sound comparative information to support the formulary selection process…
Expand
2003
2003
[A descriptive analysis of naratriptan use among migraineurs in ambulatory medicine].
F. Brudon-Mollard
,
P. Druais
,
+5 authors
A. El Hasnaoui
Revue neurologique (Paris)
2003
Corpus ID: 34629063
The objective of this study was to provide an epidemiological description of naratriptan use in ambulatory medicine. 1695…
Expand
2003
2003
Model-based Integration for Clinical Trial Simulation and Design: A Phase ll Case Study for Naratriptan
I. Nestorov
,
G. Graham
,
L. Aarons
,
S. Duffull
2003
Corpus ID: 58583125
There is recent and growing interest in using computer simulation of clinical trials to improve clinical trial design. Simulating…
Expand
2001
2001
Building on the Sumatriptan Experience: The Development of Naratriptan
H. Connor
Cephalalgia
2001
Corpus ID: 35364331
1997
1997
Naratriptan provides effective migraine control
L. Prescott
1997
Corpus ID: 71420913
A number of recent clinical trials have demonstrated that naratriptan [Glaxo Wellcome], a new potent and selective 5HTIB…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE